A REVIEW OF THERAPEUTIC PSYCHEDELICS

(2016) emphasize that evidence for efficacy of common medication or psychotherapy is weak and even detrimental.A little laboratory study revealed on psilocybin, copyright, and mescaline recommended that these copyright drugs are “weakly reinforcing,” indicating their use is not likely to lead to a substance use problem.In June 2023, the FDA rel